# STOCKHOLM 1.0
#=GF ID   Triabin
#=GF AC   PF03973.17
#=GF DE   Triabin
#=GF AU   Finn RD;0000-0001-8626-2148
#=GF SE   Pfam-B_20829 (release 7.1)
#=GF GA   21.00 21.00;
#=GF TC   21.00 21.00;
#=GF NC   20.90 20.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -E 1000 -Z 75585367 HMM pfamseq
#=GF TP   Domain
#=GF CL   CL0116
#=GF RN   [1]
#=GF RM   9342325
#=GF RT   Structure of the thrombin complex with triabin, a lipocalin-like
#=GF RT   exosite-binding inhibitor derived from a triatomine bug. 
#=GF RA   Fuentes-Prior P, Noeske-Jungblut C, Donner P, Schleuning WD,
#=GF RA   Huber R, Bode W; 
#=GF RL   Proc Natl Acad Sci U S A 1997;94:11845-11850.
#=GF DR   INTERPRO; IPR005657;
#=GF DR   SCOP; 1avg; fa;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   Triabin is a serine-protease inhibitor with a calycin fold [1].
#=GF SQ   4
#=GS Q94731_RHOPR/19-155  AC Q94731.1
#=GS Q94732_RHOPR/18-162  AC Q94732.1
#=GS PALL_MECPA/19-165    AC Q27042.1
#=GS TRIA_MECPA/19-160    AC Q27049.1
Q94731_RHOPR/19-155             AN....PPKMPTGCKDLNSKAVKDFKYNDFFK.DKWILTHAERVTHPDACETFTVNGN.K..........ITFS..LGGKEVSCTLVKVEGAK..FTKFNCELQG.....KKFTAYLSVLATDYKNYALVYRCGSH.ESPTKDNFLVAQRRKQSTFPSALESQ
Q94732_RHOPR/18-162             AAGASATTTMPKECLELKGDIKPGFDANQFFT.GDWYWTHARDPKHPKLCQKYQATSD..........LRLKFNG.NSGSDVTCQGAKVIGKEG.FYSFQCTTSG.....VTFTSFMAVVETDYNNYALLYRCGRYGSSAVEDNFLVFNRQSSGGIPGGLTTK
PALL_MECPA/19-165               EE....CELMPPG.........DNFDLEKYFSIPHVYVTHSRNGPKEQVCREYKTTKNSDGTTTTLVTSDYKTGGKPYHSELKCTNTPKSGVKG.QFSVECEVPNGNGGKKKIHVETSVIATDYKNYALLQSCTKT.ESGIADDVLLLQTKKEGVDPG.VTSV
TRIA_MECPA/19-160               AE..........GDDCSIEKAMGDFKPEEFFN.GTWYLAHGPGVTSPAVCQKFTTSGS.KGFTQIV...EIGYN..KFESNVKFQCNQVDNKNGEQYSFKCKSSDN....TEFEADFTFISVSYDNFALVCRSITFTSQPKEDDYLVLERTKSDTDPDAKEIC
#=GC seq_cons                   Ap....s.hMP.Gs.p..tchhssFchpcFFs.scWYlTHucsss+PplCpcapsous.c.........clpas...htS-VpCpsspVpGtcG..aSFpCcsss.....pcFpu.hoVluTDYcNYALlhRCspa.pSshcDsaLVhpRpKpus.Puulpop
